Friday, 13 July 2018

Global Therapeutic Landscape of Cell Therapy Market Pipeline Review, 2018


Market Scenario
Cell therapy has come forward as a recent phase of the biotechnology revolution in medical sector. As cell therapy is based on ground-breaking scientific discoveries and various technological advancements. The main aim of cell therapy is to target various diseases at the cellular level by restoring a certain cell population as carriers of therapeutic cargo. It is also used in combination with gene therapy for many diseases. For many diseases, gene and cell therapy are applied in combination.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5066

With new technologies, and different types of cells such as hematopoietic stem cells (HSC), mesenchymal stem cells, skeletal muscle stem cells, lymphocytes, pancreatic islet cells, and dendritic cells, cell therapy can be used for the treatment of a variety of diseases. Hematopoietic stem cell transplantation or Bone marrow transplant is the most commonly used cell therapy to treat a variety of hematologic conditions and blood cancers. Potential applications of cell therapy include treatment of cancers, urinary problems, autoimmune disease, and infectious disease, repairing spinal cord injuries, rebuilding damaged cartilage in joints, improving the immune system, and treatment of neurological disorders.
Adipose tissue-derived stem cells (ADSCs) are another most promising cell types for application in regenerative therapies. Regenerative medicine is an interdisciplinary field comprises of tissue engineering, with an objective of restoration or establishment of the normal functioning of organs.
It is estimated that cell therapy market is expected to grow at a CAGR 10.6% during the forecast period of 2017-2023.
Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/5066

Segmentation
The cell therapy market is segmented on the basis of type, technology, cell source, application, and end-user.
On the basis of type, the market is segmented into autologous, and allogeneic.
On the basis of technology, the market is classified into somatic cell technology, cell immortalization technology, viral vector technology, genome editing technology, cell plasticity technology, and three-dimensional technology. Viral vector technology is further segmented into Ex vivo gene modification of cells and In vivo gene modification of cells.
On the basis of cell source, the market is classified into induced pluripotent stem cells (iPSCs), bone marrow, umbilical cord blood-derived cells, adipose tissue, and neural stem cell.
On the basis of application, the market is classified into musculoskeletal, cardiovascular, gastrointestinal, neurological, oncology, dermatology, wounds and injuries, ocular, and others.
On the basis of end-users, the market is segmented into hospital & clinics, regenerative medicine centers, diagnostic centers, research institutes, and others.
Detailed Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
LIST OF TABLES
Table 1 Cell Therapy Industry Synopsis, 2017 – 2023
Table 2 Cell Therapy Market Estimates And Forecast, 2017 – 2023, (USD Million)
Table 3 Cell Therapy Market By Region, 2017 – 2023, (USD Million)
Table 4 Cell Therapy Market By Type, 2017 – 2023, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Cell Therapy Market
Figure 3 Segmentation Market Dynamics For Cell Therapy Market
Figure 4 Global Cell Therapy Market Share, By Type 2016

...Continued
Key Players
Some of key the players in the cell therapy market are Novartis AG, GlaxoSmithKline plc, MEDIPOST, Osiris, PHARMICELL, NuVasive, Inc., JCR Pharmaceuticals Co., Ltd, ANTEROGEN.CO.,LTD., Cynata, CELLECTIS, BioNTech IMFS, EUFETS GmbH, Cognate, Pluristem, Grupo Praxis, Genzyme Corporation, Advanced Tissue and others. 

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/5066

         
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Posted by at No comments:
Labels:

Acute Hospital Care Market Research Report 2018 Analysis and Forecast to 2023


Market Scenario:
Acute care is a branch of health care in which short-term treatment is provided to patients with medical conditions such as severe injury and recovery from surgery. Acute conditions such as asthma attack, broken bone, bronchitis, burn, common cold, flu, heart attack, pneumonia, and others require treatment in acute hospital care. Various services are included in acute hospital care such as coronary care, intensive care, neonatal intensive care, cardiology, and others. The acute care market growth is majorly attributed due to the rising incidences of trauma injury, the presence of a large base of the patient population, increasing number of hospital, unmet medical needs in emerging economies. Moreover, the geriatric population having acute diseases are projected to boost the market growth over the forecast period.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4931

According to the American Academy of Allergy, Asthma & Immunology, during 2011-2014, asthma prevalence was 8.8% among all adults. During this period, asthma was more common among adults with obesity (11.1%) compared with adults in normal weight (7.1%) and overweight (7.8%) people.

As per reports from American Academy of Orthopedic Surgeon, broken bones are a common injury i.e an average of 6 million people in the U.S is likely to break a bone each year. Most of these broken bones heal without problems. However, about 300,000 patients are slow to heal or do not heal at all with traditional methods. Since broken bone is a common problem, it needs acute hospital care, Therefore,  it is estimated to fuel the market growth during the forecast period.

However, limited availability of facilities and equipment may hamper the market growth during the forecast period.
The global acute hospital care market is expected to grow at a CAGR of ~7.8% during the forecast period 2017-2023.

Key players for Acute Hospital Care market
Some of key the players in the market are HCA Holdings, Inc. (U.S.), Community Health Systems LLC (U.S.), Universal Health Services, Inc. (U.S.), Tenet Healthcare Corp. (U.S.), Vanguard Health System Inc. (U.S.), Ardent Health Services (U.S.), Kindred Healthcare, Inc. (U.S.), PruittHealth (U.S.), National HealthCare Corp.(U.S.), and others.

Segmentation
The global acute hospital care market is segmented on the basis of medical condition and services.

On the basis of the medical condition, it is segmented into emergency care, urgent care, short-term stabilization, pre-hospital care, critical care, trauma care, and acute care surgery.  

On the basis of the services, it is segmented into coronary care, intensive care, neonatal intensive care, cardiology, and emergency department.

Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/4931
Regional Analysis
The Americas dominate the global acute hospital care market owing to well-developed technology, increasing patient population, high health care spending, and increasing government support for research & development. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the market in this region.
Europe holds the second position in the global acute hospital care market owing to the government support for research & development and availability of funds for research. This is expected to continue to drive the European market over the forecasted period. For instance, developed economies such countries such as Germany and France are increasing investment in the healthcare domain and are focusing more on hospital infrastructure.   
Asia Pacific is the fastest growing acute hospital care market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing demand for acute hospital care in countries like India and South Korea are likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare is projected to lead the use of advanced equipment, which, in turn, may increase the market growth in this region.
On the other hand, the Middle East & Africa holds the least share of the market owing to less availability of funds, limited medical facilities, and deprived political conditions in Africa. 

BRIEF TABLE OF CONTENT
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
Send An Enquiry @  https://www.marketresearchfuture.com/enquiry/4931

         
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Posted by at No comments:

Microsurgery Market in depth study and analysis published, 2018


Market Scenario
Microsurgery is a procedure that combines magnification and specialized precision tools & techniques during the surgery. These techniques are majorly used for the treatment of cancer & congenital deficiencies. It helps to heal wounds and restore function after trauma & cancer. The first microsurgery was performed in 1960 by Jules Jacobson.
The major driving factor for the market is increasing prevalence of the cancer, ophthalmic diseases and other chronic diseases. According to Cancer Research UK, in 2012, 14.1 million people across the globe were suffering from cancer. Increasing number of organ transplantation, advances in the surgical procedures and adoption of microscope in surgeries have also driven the market growth. Moreover, high healthcare expenditure, increasing geriatric population, and growing need for the better treatment of the diseases have fueled the market growth. However, high cost of the treatment and poor reimbursement policies for the medical devices may slower the market growth.
The global microsurgery market is expected to grow at a CAGR of 10.2% during the forecast period of 2017-2023.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4214

Key Players        
Some of the key players in microsurgery market are AROSurgical Instruments (US), tisurg medical instruments Co., Ltd (China), Carl Zeiss Meditec AG (Germany), MicroSurgical Technology (US), SYNOVIS MICRO COMPANIES ALLIANCE, INC. (US), Peter LAZIC GmbH (Germany), BIONIKO (US), MICROSURGERY INSTRUMENTS, INC. (US).
Segments    
The global microsurgery market is segmented on the basis of application, procedures, and end users. On the basis of applications the market is categorized into: general surgery, ophthalmology, plastic surgery, gynecological surgery, orthopedic surgery, oncology, neurosurgery, oral & maxillofacial surgery, podiatric surgery, and pediatric surgery.
On the basis of procedures the market is segmented into free tissue transfer, replantation, transplantation, and treatment of infertility. Replantation is further segmented into fingers & thumbs, ear, scalp, nose, and others. Treatment of infertility is further segmented into tubal obstructions, vas deferens obstructions and varicocele.
On the basis of end users the market is segmented into hospitals & clinics, research organizations and others.
Regional Analysis              
The Americas account for the largest share of the global market owing to increasing cancer population, increasing prevalence of neurological diseases and deficiency diseases, and high healthcare spending. According to Centers for Disease Control and Prevention (2014), over 1.5 million cases of invasive cancer, including about 15,000 cases among children younger than 20 years are registered every year. Beside this increasing government support for research & development has supported the growth of the market.
Europe accounts for the second largest market which is followed by Asia Pacific. Availability of funds for research & development, increasing awareness about availability of treatments and well developed healthcare sector drives the market of microsurgery. On the other hand, Asia Pacific holds the fastest growth for microsurgery market owing to increasing number of people suffering from chronic diseases, elevating geriatric population, and demand for better treatments are the key factors for the market growth. China and India holds the major share for the market due to large patient pool.
The Middle East & Africa is expected to show steady growth in this market due to low technology penetration and limited availability of innovative healthcare technologies.
Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/4214

Detailed Table of Contents:
1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3 Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
...Continued

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/4214
       
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com


Posted by at No comments:

Wednesday, 11 July 2018

Magnetic Resonance Imaging (MRI) Market Competitive landscape By 2023

Market Scenario
The global Magnetic Resonance Imaging (MRI) Systems market is expected to be of value USD 5 Billion in 2023 and to grow at a depict 3.5% CAGR during the forecast period.  Magnetic resonance imaging (MRI) systems is a non-invasive technique in which light is used to interrogate cellular and molecular function in the living body by exploiting the special properties of photons. Magnetic resonance imaging (MRI) systems are surpassing the radiology imaging market due to its myriad advantages over it. This market is mainly driven by rising demand for non-invasive procedures, harmful effects of radiation-based imaging, increase in research and development activities in the life sciences sector, and increasing application of magnetic resonance imaging (MRI) systems techniques in drug discovery processes and preclinical research, Moreover factors such as rising geriatric population which leads to increase in cardiovascular, neurological and ophthalmic disorders is also fueling the growth of this market. However, the market growth is restricted by factors such as stringent regulatory approval procedures high costs of instruments, scarcity of skilled operators, and insufficient reimbursements policies for magnetic resonance imaging (MRI) systems procedures.
Market Segmentation                                                                                                                          
The global magnetic resonance imaging (MRI) systems market is segmented on the basis of type, field strength, disease application and end user.
Considering the type, the market is segmented into open MRI, closed MRI, standard bore MRI, wide-bore MRI.
On the basis of field strength, the market is segmented into high-field MRI systems, 1.5t MRI systems, 3t MRI systems, low-to-mid-field MRI systems, very-high-field MRI systems, and others.
On account of disease application, the market is segmented into the spine and musculoskeletal MRI, brain and neurological MRI, pelvic and abdominal MRI, breast MRI, cardiovascular MRI, and others
According to the end user, the market is segmented into diagnostic imaging centers, hospitals and clinics, research laboratories, and pharmaceutical &biotechnology companies.
Based on region the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. The American region is segmented into North America and South America. Similarly, Europe is segmented into Western Europe and Eastern Europe.
Market Players
  • Hitachi
  • Siemens AG
  • Canon Medical Systems
  • GE Healthcare
  • Philips
  • Toshiba Corporation
  • Toshiba Corporation
  • Xingaoyi
  • Aurora Imaging Technologies, Inc.
Regional Market Summary
In terms of geography, Americas dominates the market for Magnetic Resonance Imaging (MRI) systems owing to increasing prevalence of cardiovascular, neurological and ophthalmic disorders pertaining to rising geriatric population which is a major trigger factor for this disease. Additionally, factors such as increasing government initiatives and funding for research in the medical devices sector, rising demand for accurate diagnosis, awareness about adverse effects of radiation imaging, ability to provide in-depth images of soft tissues and vascular systems, and the presence of pharmaceutical giants also propel the market growth in this region. For instance, according to National Center for Health Statistics report in 2016, around 140,323 mortality occurred due to cerebrovascular disease or stroke in the US Thus, this rising patient pool is going to boost up the market growth during the forecast period.
Europe accounts for the second largest market and holds a healthy share in the global magnetic resonance Imaging (MRI) systems market due to major driving factors like availability of advanced treatment facilities, increasing healthcare expenditure, good healthcare infrastructure and flourishing medical device industry due to the presence of major market players. Additionally, knowledge about the benefits of Magnetic Resonance Imaging (MRI) Systems over radiation imaging and capability of inhabitants to afford the diagnostics is spurring the market growth.
Asia Pacific is expected to be the fastest growing market with most promising growth possibilities. According to a report published by the Department of Neurology in 2014, it is estimated that for the current population of 1.27 billion, approximately 30 million people suffer from neurological disorders in India. Thus, owing to the huge patient pool, a faster adaptation of healthcare technology, government initiatives to increase the healthcare quality, availability favorable insurance policies market growth will be accelerated during the forecast period.  Moreover, due to lower cost of clinical trials and research key players have been setting up their regional headquarters and manufacturing plants in Singapore, China, Japan, Korea, and Australia which make a positive growth curve in  Magnetic Resonance Imaging (MRI) Systems market in future.
 The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates and Saudi Arabia is the largest market share owing to the development of healthcare industry and rising availability of specialty care centers. Hence, the market might show steady growth due to Saudi Arabia, the UAE market growth, and government initiatives to improve quality of healthcare in the Africa region.
Table Of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Subscribe to: Posts (Atom)